SOURCE: Eurand N.V.

Eurand N.V.

May 01, 2009 08:30 ET

Eurand to Present at Upcoming Investor Conferences

PHILADELPHIA, PA--(Marketwire - May 1, 2009) - Eurand N.V. (NASDAQ: EURX), a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products based on its proprietary pharmaceutical technologies, announced today that Gearóid Faherty, Chairman and Chief Executive Officer, is scheduled to present at the following upcoming conferences:

Event:    Bank of America and Merrill Lynch 2009 Health Care Conference
Date:     Thursday, May 14, 2009
Time:     9:20 a.m. ET
Place:    New York Palace Hotel
          455 Madison Ave.
          New York, N.Y.

Event:    Deutsche Bank 34th Annual Health Care Conference
Date:     Monday, May 18, 2009
Time:     2:25 p.m. ET
Place:    InterContinental Boston
          510 Atlantic Avenue
          Boston, Mass.

An audio webcast of the Company's presentation at each conference will be available by accessing the investor relations section of Eurand's web site at www.eurand.com and will be available via replay for 30 days following the date of the presentation.

About Eurand

Eurand is a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary pharmaceutical technologies. Eurand has had four products approved by the FDA since 2001 and has a pipeline of product candidates in development for itself and its collaboration partners. Its technology platforms include bioavailability enhancement of poorly soluble drugs, custom release profiles, taste-masking orally disintegrating tablet (ODT) formulations, and drug conjugation. Eurand is a global company with facilities in the U.S. and Europe. For more information, visit Eurand's website at www.eurand.com.

Contact Information